China’s NMPA Issues Guidelines for Onsite Inspections of Medical Device Companies
The National Medical Products Administration (NMPA) of China has released the “Guidelines for Onsite Inspection...
Fineline Cube
WuXi AppTec’s H1 2024 Financials Reflect Decline Amid Biosecure Act Challenges
China-based Contract Development and Manufacturing Organization (CDMO) WuXi AppTec (HKG: 2359) has reported a subdued...
Roche Completes Acquisition of LumiraDx’s Point-of-Care Solutions Business
Swiss pharmaceutical and diagnostics giant Roche (SWX: ROG, OTCMKTS: RHHBY, SWX: RO) has announced the...
Philips Posts 2% Q2 2024 Sales Growth, Boosted by North American Demand
Royal Philips (NYSE: PHG), the Dutch electronics giant, reported its financial results for the second...
GSK Enters into Strategic Partnership with Flagship Pioneering to Develop Novel Medicines and Vaccines
UK pharmaceutical giant GlaxoSmithKline (GSK; NYSE: GSK, LON: GSK) has announced a new partnership with...
Novartis’s Scemblix Receives FDA Priority Review for First-Line CML Treatment
Swiss pharmaceutical giant Novartis (NYSE: NVS) has announced that the US Food and Drug Administration...
Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for SHR-A1921 Clinical Study in Advanced Solid Tumors
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company in China, has announced...
Porton Pharma Solutions Partners with Guangzhou Geneseed Biotech to Advance circRNA Therapies
Porton Pharma Solutions Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
ShuWen Biotech’s Preeclampsia Self-Test Receives NMPA Approval, Marking a Global First
Zhejiang-based ShuWen Biotech Co., Ltd has announced that it has received marketing approval from China’s...
Livzon Pharmaceutical Group to Establish Joint Venture with PT Kalbe Farma in Indonesia
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced plans to form a joint venture...
Organon’s Liptruzet Launches in China for Hypercholesterolemia Treatment
US pharmaceutical company Organon (NYSE: OGN) has announced the official market launch of its single-tablet...
LTZ Therapeutics Secures Over USD 20 Million in Series A Financing to Advance Immunotherapy Pipeline
LTZ Therapeutics Inc., a biotechnology company specializing in immunotherapy with operations in both the US...
Shanghai Sanyou Medical Gains NMPA Approval for 3D Printed Cervical Fusion Device
Shanghai Sanyou Medical Co., Ltd (SHA: 688085), a prominent player in the medical device industry...
Guangzhou Red Pine Medical Secures Series D Funding to Accelerate Global Expansion
Guangzhou Red Pine Medical Instrument Co., Ltd., a leading company in the disposable endoscope sector,...
China’s H1 2024 Pharmaceutical Trade Data Indicates Mixed Performance in Global Markets
The Ministry of Industry and Information Technology (MIIT) has released a report on the first...
China’s NHC Reports 2023 County Hospital Medical Service Capability Evaluation Results
The National Health Commission (NHC) of China has released a notice detailing the results of...
EU Regulator Rejects Marketing Authorization for Biogen and Eisai’s Alzheimer’s Drug Leqembi
Biogen Inc. (NASDAQ: BIIB), a US biotechnology company, and its Japanese counterpart Eisai Co., Ltd...
Yipinhong Pharmacy Repays $36.7 Million in Bromhexine Marketing Settlement
Yipinhong Pharmacy Co., Ltd (SHE: 300723), a China-based pharmaceutical company, has made a significant repayment...
Luye Pharma’s Antipsychotic Erzofri Gains FDA Nod for Schizophrenia Treatment
Luye Pharma Group (HKG: 2186), a leading pharmaceutical company based in China, has achieved a...
AstraZeneca Charts Comprehensive Anti-Obesity Strategy with GLP-1 and Amylin Therapies
AstraZeneca (AZ; NASDAQ: AZN), a UK-based pharmaceutical giant, has outlined its strategic advancements and future...